✓ No loaded language, vague sourcing, or framing detected.
The FDA is set to announce its decision on Moderna's mRNA-based flu vaccine, which could be the first of its type to be approved. This decision is anticipated to impact the biotechnology industry significantly.
Our neutral summary
The FDA is set to announce its decision on Moderna's mRNA-based flu vaccine, which could be the first of its type to be approved. This decision is anticipated to impact the biotechnology industry significantly.
The reporting belongs to NPR — Top Stories; we don't reproduce it.
No note attached
on this article.
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
FDA to Decide on Moderna's mRNA-based Flu Vaccine